title: Rizatriptan tablet versus wafer: patient preference.
abstract: After taking both conventional oral rizatriptan tablets and oral disintegrating rizatriptan tablets in the treatment of migraine with or without aura, patients were permitted to select their formulation preference. All adult patients who had requested continuation of rizatriptan during a 6-month period were included in the study. Of the 367 patients studied, 188 selected the oral disintegrating tablet, while 179 preferred the conventional tablet. Although individual patients had strong preferences for one preparation over the other, no group preference was found.
authors.affiliation: Headache Wellness Center, Greensboro, NC 27403, USA.
authors.forename: J U
authors.initials: JU
authors.lastname: Adelman
authors.forename: L K
authors.initials: LK
authors.lastname: Mannix
authors.forename: R L
authors.initials: RL
authors.lastname: Von Seggern
mesh_terms: D000328:Adult; D004304:Dosage Forms; D004341:Drug Evaluation; D005612:Freeze Drying; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D017060:Patient Satisfaction / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage*; D013607:Tablets; D014230:Triazoles / Q000008:administration & dosage*; D014363:Tryptamines
chemical_list: D004304:Dosage Forms; D017366:Serotonin Receptor Agonists; D013607:Tablets; D014230:Triazoles; D014363:Tryptamines; C093622:rizatriptan